Author

admin

Browsing

Genetics is the study of genes, their variations and hereditary characteristics, as well as how these traits are passed on through generations. So what is genetics investing?

When it comes to genetics investing, companies in this niche of the life science sector are mostly focused on four submarkets: DNA sequencing, genetic testing, gene therapy and genomics, which includes gene editing.

This life sciences submarket has gained much attention from investors over the past several years. It has provided a launching pad for a number of biotech firms developing and commercializing novel treatments and drugs addressing a wide range of diseases with unmet needs.

For those looking to dive into the genetics sector, there are numerous investment opportunities to consider. Investing in gene stocks is the most common route, but there are risks due to the market’s volatility, especially when it comes to wins or losses with the US Food and Drug Administration (FDA).

Exchange-traded funds (ETFs) are another popular option for gaining exposure to the industry, and come with less risk than investing in a single stock.

In this article

    What are the key areas of the genetics sector?

    Before diving into investment opportunities in the genetics market, it’s important to understand the industry and the key areas of genetics mentioned above.

      What investors should know about the genetics market

      In the biotech sector, gene therapy is one of the more advanced treatment options, and gene therapy pipeline candidates are robust in late-stage clinical trials.

      In terms of what will — and already has — disrupted the genetics industry, CRISPR gene-editing technology has been on the rise for quite some time. It uses short repeating DNA sequences with “spacers” dividing them to treat genetic diseases.

      While the use of the technology is still in its early stages, in the coming years it’s expected to have a big impact on how genetic diseases are treated, and there are a range of clinical trials underway involving CRISPR technology. So far, the only FDA approved CRISPR-based medicine is Casgevy, developed by Vertex Pharmaceuticals (NASDAQ:VRTX) and CRISPR Therapeutics (NASDAQ:CRSP). It was originally approved in late 2023 for the treatment of sickle cell disease.

      The prominence of gene therapies in the life science sector was a major theme at the 2025 JPMorgan Healthcare Conference in January 2025. Peter Marks, then-director of the FDA’s Center for Biological Evaluation and Research, told attendees that his agency is aiming to accelerate approvals for gene therapies.

      In 2024, the FDA expanded approvals for CRISPR-based Casgevy to beta-thalassemia, and it also approved Pfizer’s (NYSE:PFE) Beqvez and PTC Therapeutics’ (NASDAQ:PTC) Kebilidi.

      Despite experiencing a challenging year in 2024, there is still a lot of optimism in the gene therapy sector. Also speaking at the January conference, Alliance for Regenerative Medicine president Tim Hunt said he believes 10 new cell and gene therapy treatments could reach blockbuster status by 2030.

      “No one’s saying there aren’t headwinds, but we are seeing important signs of growth,” he added.

      Looking at DNA sequencing, this market is driven by advances in biotech, the increasing prevalence of cancer and rising demand for precision medicine, as well as higher investment in research and development. DNA sequencing has become a vital component of this growth and has played a key role in remodeling molecular biology and genomics research.

      Genetic testing is another segment of the genetics industry that is growing at a fast pace. Unsurprisingly, technological breakthroughs have had a huge impact on genetic testing, and so has the fact that governments and regulatory bodies are turning their attention to this market in order to regulate and raise awareness to treat diseases such as cancer, cystic fibrosis and sickle cell anemia.

      Biotech and pharmaceutical companies are also expressing interest in this sector, which is expected to further fuel genetics sector growth in the coming years. Mergers and acquisitions activity is also expected to increase as companies seek to expand their product portfolios new candidates and technologies.

      As can be seen, the genetics industry is vast and complex, but is also ripe with investment opportunities.

      How to invest in gene stocks

      Investors looking to invest in the field of genetics through stocks have many options, from large-cap biotech companies to pure-play gene therapy, gene editing and genetic testing stocks.

      See the list below for genetics companies to consider, and check out the linked stock lists for more options.

      Large-cap gene stocks

      There are a number of large-cap biotech companies that have significant focuses on the field of genomics. Here are a few to consider:

      Amgen (NASDAQ:AMGN)
      A global leader in biotech, Amgen uses advanced human genetics to develop and manufacture therapeutics targeting a variety of diseases with unmet medical needs. The company’s subsidiary deCODE Genetics is researching how human genetic diversity influences disease.

      AbbVie (NYSE:ABBV)
      Research-based global biopharmaceutical company AbbVie that addresses several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology and gastroenterology. AbbVie is collaborating with ADARx Pharmaceuticals to develop siRNA therapeutics, viewed as a promising genetic medicine approach for silencing disease-causing genes.

      Regeneron Pharmaceuticals (NASDAQ:REGN)
      Regeneron Pharmaceuticals creates medicines for a wide variety of diseases. The Regeneron Genetics Center is conducting one of the world’s largest genetics sequencing efforts in collaboration with health organizations around the world.

      Gene editing (CRISPR) stocks

      There are a variety of options for investors looking to buy in on the field of gene editing stocks, including:

      CRISPR Therapeutics (NASDAQ:CRSP)
      CRISPR Therapeutics and its partner Vertex Pharmaceuticals co-developed drug Casgevy, a CRISPR/Cas9 genome-edited cell therapy. Casgevy is the first ever treatment based on CRISPR technology to be approved for the US market, as well as by the European Medicines Agency and Health Canada.

      Intellia Therapeutics (NASDAQ:NTLA)
      Intellia Therapeutics is a gene editing biotech company developing drugs for patients with genetic and autoimmune diseases. The company’s drug pipeline includes late-stage clinical programs for therapies targeting hereditary angioedema and transthyretin amyloidosis.

      Vertex Pharmaceuticals (NASDAQ:VRTX)
      Vertex Pharmaceuticals is the other half of the team behind Casgevy. It also offers exposure to other sectors of genomics, with approved treatments for cystic fibrosis and a pipeline of genetic and cell therapies. Its investigational VX-880 islet cell replacement therapy could restore insulin production in patients with type 1 diabetes.

      Gene therapy stocks

      Gene therapy stocks and stem cell stocks are also popular choices for genetics investing. Here are a few to get you started:

      Novartis (NYSE:NVS)
      Switzerland-based Novartis is focused on treatments for a wide range of diseases, including cancers, malaria, leprosy and sickle cell disease. Novartis is developing adeno-associated-virus (AAV)-based and CRISPR-based gene therapies. Its Kymriah treatment was the first CAR-T cell therapy to be approved by the FDA, and the agency also approved its AAV-based therapy Zolgensma.

      Gilead Sciences (NASDAQ:GILD)
      Global biopharmaceutical company Gilead Sciences is advancing breakthrough medicines to prevent and treat serious diseases such as HIV, viral hepatitis and cancer. Its cell-based gene medicine for blood cancer, the CAR T-cell therapy Yescarta, was the second gene therapy approved by FDA.

      uniQure (NASDAQ:QURE)
      Genomic medicine company uniQure develops and markets gene therapy products for patients with severe genetic diseases. The company’s AAV-based gene therapy platform targets liver-directed and central nervous system disorders.

      Genetic testing stocks

      For those interested in genetic testing stocks, these three stocks provide a snapshot on different ways to get exposure to the sector:

      Exact Sciences (NASDAQ:EXAS)
      Exact Sciences focuses on molecular diagnostic tests. The company has developed a molecular screening technology platform called Cologuard that detects a range of cancers, including breast cancer and colorectal cancer.

      Fulgent Genetics (NASDAQ:FLGT)
      A leader in clinical diagnostic genetic sequencing, Fulgent Genetics is a full-service genomics testing company. Its proprietary technology platform, Picture Genetics, allows for the identification of personal DNA health markers in individual patients.

      Illumina (NASDAQ:ILMN)
      Illumina develops, manufactures and markets life science tools and integrated systems that enable the implementation of genomic solutions for the healthcare sector. Its focus is on oncology testing, genetic disease testing, reproductive health and research.

      How to invest in genomics ETFs

      For those who would prefer to invest in the genetics industry overall rather than buying shares in an individual gene stock, investing in genomics ETFs is the way to go. Here are some available ETFs that offer exposure to companies in the biotech and genetics sectors to start you off:

      ARK Genomic Revolution ETF (ARCA:ARKG)
      This ETF tracks firms focused on CRISPR technology, targeted therapeutics, bioinformatics, molecular diagnostics, stem cells and agricultural biology. Its holdings include CRISPR Therapeutics and Guardant Health (NASDAQ:GH).

      Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)
      The Global X Genomics & Biotechnology ETF invests in stocks that are involved in genomic science, which includes gene computational genomics and biotechnology. Its holdings include Illumina and Avidity Biosciences (NASDAQ:RNA).

      iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA)
      The iShares Genomics Immunology and Healthcare ETF focuses on companies involved with genomics, immunology and bioengineering. Its holdings include Regeneron Pharmaceuticals and Arcellx (NASDAQ:ACLX).

      Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.

      This post appeared first on investingnews.com

      Bipartisan anger is brewing over the drama that unfolded at the Centers for Disease Control (CDC), with the top members of the Senate’s healthcare panel forming a united front in the midst of the turmoil.

      Senate Healthcare, Education, Labor and Pensions Committee Chair Bill Cassidy, R-La., and the panel’s ranking member, Sen. Bernie Sanders, I-Vt., dove head first into the issues stemming from the firing of CDC Director Susan Monarez, which spurred a string of departures from the agency.

      Monarez was abruptly fired from her position by the Department of Health and Human Services (HHS), less than a month after being confirmed by the Senate. Her removal, which her lawyers rejected, appeared to stem from disagreements over vaccines with HHS Secretary Robert F. Kennedy, Jr., a vaccine skeptic.

      Cassidy was the deciding vote during Kennedy’s confirmation hearing earlier this year.

      Monarez has since refused to leave the post, with her lawyers arguing that she had neither resigned nor been fired and had not received notification from the president of her removal.

      Following news of her ouster, a string of top officials at the CDC announced their resignations, too, including National Center for Emerging and Zoonotic Infectious Diseases Director Dr. Daniel Jernigan, Chief Medical Officer Debra Houry, National Center for Immunization and Respiratory Diseases Director Demetre Daskalakis and Director of Public Health Data, Science, Technology Jennifer Layden.

      In response to their resignations, Cassidy demanded that the federal government’s vaccine advisory panel, which was filled with Kennedy’s handpicked replacements after he recently booted the original panel members, postpone its scheduled meeting in September.

      His demand marks the second time this year that Cassidy called on the panel to halt its meeting, a move that directly bucks Kennedy’s and President Donald Trump’s Make America Healthy Again (MAHA) agenda. 

      Cassidy argued Thursday that there were ‘serious allegations made about the meeting agenda, membership, and lack of scientific process being followed for the now announced September [Advisory Committee on Immunization Practices] meeting.’

      ‘These decisions directly impact children’s health, and the meeting should not occur until significant oversight has been conducted,’ Cassidy said. ‘If the meeting proceeds, any recommendations made should be rejected as lacking legitimacy given the seriousness of the allegations and the current turmoil in CDC leadership.’

      Daskalakis posted his reason for resigning on X, where he charged that he was ‘unable to serve in an environment that treats CDC as a tool to generate policies and materials that do not reflect scientific reality and are designed to hurt rather than to improve the public’s health.’

      Meanwhile, Sanders demanded a congressional investigation be opened into the Trump administration’s decision to fire Monarez.

      ‘We need leaders at the CDC and HHS who are committed to improving public health and have the courage to stand up for science, not officials who have a history of spreading bogus conspiracy theories and disinformation,’ Sanders said Thursday.

      HHS did not immediately respond to a request for comment for this story.  

      This post appeared first on FOX NEWS

      Investor Insight

      Cobre offers investors a rare combination of district-scale copper-silver discovery potential, near-term development upside through its ISCR-ready Ngami copper project, and a capital-light growth model underpinned by major-partner funding and diversified exposure to critical minerals.

      Overview

      Cobre (ASX:CBE) is an Australian exploration company unlocking the copper-silver potential of the Kalahari Copper Belt in Botswana, one of the world’s most prospective but underexplored sediment-hosted copper provinces. With approximately 5,348 sq km of land position, the company’s near-term focus is the Ngami copper project (NCP), where a maiden JORC resource at the Comet deposit establishes an initial copper-silver resource with strong in-situ copper recovery (ISCR) development credentials.

      Cobre’s project location in the Kalahari Copper Belt

      Cobre’s growth strategy balances district-scale discovery potential with development-ready assets, leveraging major-partner funding, including up to AU$40 million (US$25 million) investment from BHP to accelerate exploration at Kitlanya, while concentrating company capital on advancing NCP through technical, environmental and permitting milestones. The company complements its Botswana assets with strategic exposure to high-purity quartz and volcanogenic massive sulphide (VMS) opportunities in Western Australia. This diversified, capital-light approach aims to build shareholder value through discovery, derisking and development optionality.

      Company Highlights

      • Dominant land position – ~5,348 sq km across Botswana’s Kalahari Copper Belt (KCB), the second largest tenement package in the districtInvestor
      • Maiden JORC Mineral Resource – Comet deposit (Ngami copper project): 11.5 Mt @ 0.52 percent copper and 11.6 grams per ton (g/t) silver (60.3 kt copper; 4.3 Moz silver), incl. 1.1 Mt indicated @ 0.59 percent copper and 12.8 g/t silver
      • BHP partnership – Eight-year earn-in across Kitlanya East & West, allowing BHP to earn 75 percent by providing up to US$25 million for exploration expenditure, while Cobre retains exposure
      • BHP Xplor cohort – Selected in 2024, securing US$500,000 non-dilutive funding and technical support
      • Multi-jurisdiction exploration portfolio – Botswana (copper-silver), Western Australia (VMS, high-purity quartz)

      Key Projects

      Ngami Copper Project

      The 100 percent owned Ngami copper project is Cobre’s flagship asset and the primary focus of current exploration and technical work. Situated in the Kalahari Copper Belt (KCB), NCP spans multiple licences covering highly prospective sediment-hosted copper-silver targets along basin margins.

      Comet Deposit – Maiden JORC Resource

      • Announced in August 2025, the Comet deposit hosts 11.5 Mt @ 0.52 percent copper and 11.6 g/t silver, including 1.1 Mt indicated @ 0.59 percent copper and 12.8 g/t silver, at a 0.2 percent copper cut-off.
      • Contained metal: ~60,300 tonnes copper and 4.3 Moz silver.
      • Mineralisation is predominantly fine-grained chalcocite, an ideal feedstock for hydrometallurgical processing.

      In-Situ Copper Recovery Development Potential

      ISCR is a low-cost, low-impact method of producing copper by circulating a solution through the orebody underground to dissolve and pump the metal to surface for processing. For Cobre’s Ngami project, ISCR offers the potential to unlock value without the expense and disruption of conventional mining, thanks to favourable geology, high recoveries in test work, and minimal surface disturbance – positioning it as a potentially faster, cleaner and more capital-efficient path to production.

      Exploration Upside

      Beyond the initial Comet resource, Ngami hosts extensive growth potential with 40 km of mineralised strike and large, defined exploration targets that could significantly expand the resource base. Early drilling at new zones, such as the Cosmos target, has intersected high-grade copper. More than 20 km of prospective contact remains untested, offering multiple opportunities for further discoveries that could enhance scale, mine life and project economics.

      Kitlanya East & West

      Cobre’s Kitlanya East and West licences, also located in Botswana, involve an eight-year earn-in agreement with BHP. Under the deal, BHP can invest up to US$25 million to earn a 75 percent interest in Kitlanya, allowing the company to leverage a major partner’s technical expertise and funding while retaining exposure to potential tier-one discoveries. Exploration is targeting preserved fold hinge settings along basin margins – geological positions known to host large sediment-hosted copper deposits – using advanced geophysics and seismic techniques to define high-priority drill targets.

      Okavango Copper Project

      Another Botswana copper asset, the Okavango project is located along strike from MMG’s Zone 5 deposit. Okavango offers 186 km of prospective contact in the northeast Kalahari Copper Belt. Early drilling has intersected multiple zones of anomalous copper and silver mineralisation, and geophysical data shows gravity signatures comparable to those in producing areas, indicating strong potential for significant new discoveries.

      Perrinvale Project

      In addition to its African portfolio, Cobre holds the Perrinvale project in Western Australia, prospective for both high-grade VMS mineralisation and high-purity quartz (HPQ). The HPQ target has an exploration range of 5.1 to 28.3 Mt grading 99.1 to 99.6 percent SiO₂, positioning it as a potential supplier to critical silicon markets for renewable energy and electronics.

      Management Team

      Martin Holland – Executive Chairman

      Martin Holland is the founder of Cobre and co-founder of multiple ASX-listed companies, including Lithium Power International. He has more than 15 years’ experience in capital markets and resource company leadership, raising more than AU$200 million for exploration.

      Adam Wooldridge – Chief Executive Officer

      Founding partner and CEO of KML, Adam Woolridge has more than 28 years’ experience in exploration management and target generation in Africa, the Middle East and Europe.

      Ross McGowan – Non-executive Director

      CEO of Armada Metals and founder of RED Group, Ross McGowan has over 20 years of experience in African exploration, and was part of the Kamoa discovery team.

      Michael McNeilly – Non-executive Director

      Michael McNeilly, is a corporate financier and CEO of Strata Plc, with experience across multiple listed resource companies.

      Michael Addison – Non-executive Director

      Michael Addison is the founder of Endocoal, Carabella Resources and Genex Power, with extensive mining and energy development background.

      Andrew Sissian – Non-executive Director

      Andrew Sissian is co-founder of Cobre and Procon Telematics. He is a corporate and capital markets specialist with a CPA background.

      This post appeared first on investingnews.com

      The Trump administration’s latest allegations of mortgage fraud have raised questions about a long-standing housing issue known as owner-occupancy mortgage fraud. But that type of fraud can be difficult to prove, experts say.

      President Donald Trump announced in a Truth Social post on Monday night that he was removing Federal Reserve Governor Lisa Cook. He cited allegations made by Federal Housing Finance Agency Director Bill Pulte that Cook committed mortgage fraud by claiming homes in two different states as her primary residence at the same time.

      Cook’s attorney on Tuesday said Cook will file a lawsuit to challenge her removal.

      “President Trump has no authority to remove Federal Reserve Governor Lisa Cook,” the lawyer, Abbe Lowell, said in a statement.

      The Department of Justice has also recently targeted Sen. Adam Schiff, D-Calif., and New York Attorney General Letitia James with similar mortgage fraud allegations.

      Here are the key things to know about owner-occupancy mortgage fraud, according to experts.

      The main reason a borrower could be motivated to claim a primary residence on a mortgage application is to get a lower interest rate for that home.

      Typically, mortgages for a primary residence have lower interest rates and homeowner’s insurance costs, said Keith Gumbinger, vice president of mortgage website HSH.

      Mortgage interest rates are generally 0.5% to 1% higher for investment properties than for primary homes, according to Bankrate. Homeowners also typically pay about 25% more for insurance as a landlord compared with a standard homeowners policy, according to the Insurance Information Institute.

      Owner-occupied means “you’re going to live there the majority of the time,” Gumbinger said. But there are limited exceptions, including for military service, parents providing housing for a disabled adult child or children providing housing for parents, according to Fannie Mae.

      If a homeowner changes primary residences, they need to inform their mortgage lender that the original property is no longer owner-occupied, Gumbinger said.

      There are also federal and state tax benefits for primary residences, according to Albert Campo, a certified public accountant and president of Campo Financial Group in Manalapan, New Jersey.

      For example, when an owner sells a home and makes a profit, they can take a capital gains exemption worth up to $250,000 for single filers or $500,000 for married couples filing jointly, as long as they meet certain IRS rules, including owner occupancy for two of the past five years.

      For tax purposes, a homeowner can have only one primary residence at a time.

      When a taxpayer owns more than one home, proving which one is the primary residence is “always based on facts and circumstances,” Campo said. For example, a primary residence is typically where an owner spends most of their time, votes, files their tax returns and receives mail, he said.

      A 2023 report from the Federal Reserve Bank of Philadelphia found that more than 22,000 “fraudulent borrowers” misrepresented their owner-occupancy status, out of 584,499 loans originated from 2005 to 2017. The data was based on a subsample from more than 15 million loans originated during this period.

      Typically, the fraudulent borrowers took out larger loans and had higher mortgage default rates, the authors found.

      However, this type of fraud may be “difficult to detect until long after the mortgage has been originated,” the authors wrote.

      “There is a difference between the court of law and the court of public opinion,” Jonathan Kanter, a law professor at Washington University in St. Louis and a former assistant attorney general, told CNBC’s “Squawk Box” last week when asked about Cook. “In the court of law, this is small ball and very difficult to prove.”

      “You’d have to establish not only that she filled out the form incorrectly, but she had the specific intent to deceive, to defraud banks, as opposed to just making a mistake,” he said.

      During fiscal year 2024, 38 mortgage fraud offenders were sentenced in the federal system, according to the United States Sentencing Commission’s interactive data analyzer. That number is up slightly from 34 offenders in 2023, but down from 426 offenders in 2015, the earliest date in that tool’s dataset. The U.S. Sentencing Commission data does not break out the types of mortgage fraud.

      This post appeared first on NBC NEWS

      (TheNewswire)

      Harvest Gold Corporation

      Vancouver, British Columbia TheNewswire – August 28, 2025 ‑ Harvest Gold Corporation (TSXV: HVG,OTC:HVGDF) (‘ Harvest Gold ‘ or the ‘ Company ‘) is pleased to announce that its diamond drill program at the Mosseau Gold Project is well underway, with the first five holes successfully completed (see Figure 3).

      Drilling is proceeding smoothly in the northern part of the Mosseau property, an area distinguished by numerous historical gold showings and prospective geological features. This northern part of the mineralized corridor on Mosseau represents a key focus of the Company’s current program, as it offers strong potential for new discoveries in addition to increasing the size of known zones of mineralization across the area.

      The drill program is on time and on budget. Harvest Gold would like to acknowledge the excellent work being carried out by its contractors. First, Forage Rouillier’s team has ensured steady and efficient drilling progress. In addition, Explo-Logik has provided a dedicated technical and professional crew supporting field logistics, core logging, and drill core sampling. All of the Company’s protocols and procedures are being followed, with daily drilling and core logging progress reports provided to management, ensuring that the program continues to advance safely and efficiently.

      Harvest Gold has also successfully completed its regional till sampling program ahead of time and below budget across its Urban-Barry property. This initiative is designed to generate new geochemical vectors to potential gold mineralization and complements the Company’s broader exploration strategy across its property portfolio. The purpose of the program is to evaluate Urban Barry’s potential for blind gold occurrences through the study of gold grain dispersion in the secondary environment.

      The survey was conducted on a grid consisting of NW–SE sampling lines spaced approximately 1,000 to 1,500 metres apart and oriented perpendicular to the dominant ice flow, with individual sampling sites located every ~250 metres (see Figure 4).

      Of the 145 till samples originally planned, the Company successfully collected 137 samples, which contained proper surficial deposit material. Most samples were taken from depths of at least one metre, ideally below the oxidized B horizon, to reach the lodgment till. Lodgment till is a key target because it typically contains the highest proportion of material derived from proximal up-ice sources, including fragments potentially associated with gold mineralization.

      Each sample collected consisted of approximately 10 kilograms of material free from cobbles and pebbles, collected by hand shovel to ensure sample integrity. The Company expects the results from this program to provide valuable guidance for defining exploration targets across Urban-Barry.

      About Harvest Gold Corporation

      Harvest Gold is focused on exploring for near-surface gold deposits and copper-gold porphyry deposits in politically stable mining jurisdictions. Harvest Gold’s board of directors, management team and technical advisors have collective geological and financing experience exceeding 400 years.

      Harvest Gold has three active gold projects focused in the Urban Barry area, totalling 377 claims covering 20,016.87 ha , located approximately 45-70 km west of Gold Fields Limited’s – Windfall Deposit (Figure 1).

      Harvest Gold acknowledges that the Mosseau Gold Project straddles the Eeyou Istchee-James Bay and Abitibi territories.  Harvest Gold is committed to developing positive and mutually beneficial relationships based on respect and transparency with local Indigenous communities.

      Harvest Gold’s three properties, Mosseau, Urban-Barry and LaBelle, together cover over 50 km of favorable strike along mineralized shear zones.


      Click Image To View Full Size

      Figure 1: Project Location: Urban-Barry Greenstone Belt


      Click Image To View Full Size

      Figure 2: Magnetic Domains across the Northern and Central Target Areas of Mosseau


      Click Image To View Full Size

      Figure 3: Progress of drill holes completed – Northern Target Area


      Click Image To View Full Size

      Figure 4: Urban-Barry Project; Till Sampling Sites

      Qualified Person Statement

      All scientific and technical information in this news release has been prepared and approved by Louis Martin, P.Geo., Technical Advisor to the Company and considered a Qualified Person for the purposes of NI 43-101.

      ON BEHALF OF THE BOARD OF DIRECTORS

      Rick Mark
      President and CEO
      Harvest Gold Corporation

      For more information please contact:

      Rick Mark or Jan Urata
      @ 604.737.2303 or
      info@harvestgoldcorp.com

      Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

      Forward Looking Information

      This news release includes certain statements that may be deemed ‘forward looking statements’. All statements in this news release, other than statements of historical facts, that address events or developments that Harvest Gold expects to occur, are forward looking statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words ‘expects’, ‘plans’, ‘anticipates’, ‘believes’, ‘intends’, ‘estimates’, ‘projects’, ‘potential’ and similar expressions, or that events or conditions ‘will’, ‘would’, ‘may’, ‘could’ or ‘should’ occur.

      Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward looking statements include market prices, exploitation and exploration successes, and continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward looking statements are based on the beliefs, estimates and opinions of the Company’s management on the date the statements are made. Except as required by securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management’s beliefs, estimates or opinions, or other factors, should change.

      Copyright (c) 2025 TheNewswire – All rights reserved.

      News Provided by TheNewsWire via QuoteMedia

      This post appeared first on investingnews.com

      North Shore Uranium Ltd. (TSXV:NSU) (‘North Shore‘ or the ‘Company‘) is pleased to announce that it has closed the non-brokered private placement as previously announced on August 7, 2025 (the ‘Offering‘), through the issuance of 24,055,000 non-flow-through units (the ‘NFT Units‘) at a purchase price of $0.05 per NFT Unit and 3,034,922 flow-through units (the ‘FT Units‘) at a purchase price of $0.065 per FT Unit for total aggregate gross proceeds of $1,400,020.

      The Company also announces it has entered into a definitive option agreement (the ‘Option Agreement‘) with Resurrection Mining LLC (‘Resurrection‘), an arm’s length party, to acquire up to 87.5% of the Rio Puerco uranium project (‘Rio Puerco‘ or the ‘Project‘) located in northwestern New Mexico (the ‘Transaction‘). The signing of a binding term sheet (the ‘Term Sheet‘) was announced on June 24, 2025.

      Brooke Clements, President and CEO of North Shore stated: ‘This is a very exciting milestone for North Shore. The private placement was significantly oversubscribed and we would like to thank our existing shareholders and new shareholders for their support. The Rio Puerco project in New Mexico hosts a significant historical uranium resource and offers us exposure to a uranium project in the USA with excellent upside, at a time when the US government is increasing its support for the nuclear power and uranium mining sectors. The Company plans to work towards confirming and expanding upon previous work at Rio Puerco while further assessing the potential for in-situ uranium recovery. North Shore now has uranium exposure in two North American jurisdictions that have seen significant uranium production, the Grants Uranium District in New Mexico and the Athabasca Basin in Saskatchewan, at a time when the world is moving to increase its reliance on nuclear power.’

      $1.4 Million Private Placement

      Each NFT Unit consists of one non-flow-through common share and one-half of one share purchase warrant (each whole share purchase warrant, a ‘Warrant‘). Each FT Unit consists of one flow-through common share and one-half of one Warrant. Each Warrant entitles the holder to purchase one non-flow through common share (each a ‘Warrant Share‘) at a price of $0.10 per Warrant Share for a period of two years from the date of closing the Offering.

      The net proceeds of the Offering will be used to complete the Transaction, exploration of the Project, continued exploration of the Company’s Saskatchewan uranium properties, the costs of the Offering and for general working capital.

      In connection with the Offering, the Company paid cash finder’s fees of $13,500 and issued 228,462 non-transferable finder’s warrants to certain arm’s length finders. The non-transferable finder’s warrant is exercisable to acquire one common share of the Company at a price of $0.10 per share for a period of two years from the date of closing the Offering.

      All securities issued in connection with the Offering are subject to a four-month and one-day hold period from the date of closing the Offering. The Offering is subject to the final approval of the TSX Venture Exchange (the ‘Exchange‘).

      The completion of the Offering satisfied a closing requirement of the Transaction which required the Company to complete a financing raising a minimum of $750,000.

      Insider Participation

      Brooke Clements, Director, President and CEO of the Company, James Arthur, a Director of the Company, and Doris Meyer, a Director of the Company, participated in the Offering. These purchases constitute as related party transactions pursuant to Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (‘MI 61-101‘). There has not been a material change in the percentage of the outstanding securities of the Company that are individually or beneficially owned by Messrs. Clements or Arthur, or Ms. Meyer as a result of their participation in the Offering. The Company is exempt from the requirements to obtain a formal valuation and minority shareholder approval in connection with the participation of the insiders in the Offering in reliance of the exemptions contained in sections 5.5(a) and 5.7(1)(a) of MI 61-101, respectively, as the fair market value of the insider participation does not exceed 25% of the Company’s market capitalization as determined in accordance with MI 61-101.

      The Company obtained approval by the board of directors of the Company of the Offering, with Messrs. Clements and Arthur, and Ms. Meyer declaring and abstaining from voting on the resolutions approving the Offering with respect to their participation in the Offering. No materially contrary view or abstention was expressed or made by any director of the Company in relation thereto.

      Rio Puerco Option Agreement

      Upon closing of the Offering, and thereby satisfying the financing requirement of the Transaction, the Company entered into the Option Agreement with Resurrection to acquire up to 87.5% of the Project. The terms of the Option Agreement are substantively the same as the terms of the Term Sheet which was announced on June 24, 2025.

      Pursuant to the Option Agreement, the Company paid Resurrection a cash payment of $125,000 and issued Resurrection 7,483,000 common shares in the capital of the Company (the ‘Common Shares‘) at a deemed issue price of $0.05, so that Resurrection holds 9.99% of the Common Shares post-Offering, satisfying the Company’s Milestone 1 obligations. The 7,483,000 Common Shares issued will bear a legend restricting trading for a period of two years from the date of issuance.

      The remaining milestones and key terms of the Option Agreement are as follows:

      • Milestone 2, to earn a 40% interest in the Project: on or before 18 months after completion of the Transaction, a $250,000 payment in cash or Common Shares, at the option of North Shore, and $750,000 in exploration expenditures.
      • Milestone 3, to earn an aggregate 65% interest in the Project: on or before 36 months after completion of the Transaction, a $375,000 payment in cash or Common Shares, at the option of North Shore, and $1,000,000 in additional exploration expenditures.
      • Milestone 4, to earn an aggregate 87.5% interest in the Project: on or before 60 months after completion of the Transaction, a $500,000 payment in cash or Common Shares, at the option of North Shore, and $1,500,000 in additional exploration expenditures.
      • North Shore may elect to not continue to sole-fund exploration expenditures at any time after earning a 40% interest in Rio Puerco at which time North Shore and Resurrection will enter into a joint venture agreement to govern the funding of Rio Puerco on a proportional basis.
      • Bonus payments: For the 78-month period after completion of the Transaction, North Shore will pay Resurrection $100,000 or issue Common Shares of the same value as a bonus (the ‘Bonus Payment‘) for each million lbs. of uranium estimated in current resources defined by the Company above 5 million and up to 20 million lbs. in accordance with NI 43-101 standards, if and when such resources are defined.
      • Other terms: Resurrection shall have a participation right to maintain its 9.99% interest in the Common Shares of North Shore for 5 years from completion of the Transaction and the right, but not the obligation, to appoint one nominee to the North Shore Board of Directors. All share issuances will be subject to Canadian and US securities law and will be priced in accordance with Exchange policies.

      The Transaction constituted an ‘Expedited Acquisition’ in accordance with Exchange policies. All Common Shares issued and issuable under the Option Agreement will be issued with a restrictive period of four months and one day. The minimum deemed share price of any Common Share issuance is $0.05 and will be priced in accordance with the Exchange policies. There were no finder’s fees payable in connection with the Option Agreement.

      Technical disclosure on the Property can be found in the Company’s news release dated June 24, 2025.

      Caution to US Investors

      The securities referred to in this news release have not been and will not be registered under the United States Securities Act of 1933, as amended (the ‘U.S. Securities Act‘) or any state securities laws and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration under the U.S. Securities Act and applicable state securities laws, unless an exemption from such registration is available. This news release does not constitute an offer for sale of securities for sale, nor a solicitation for offers to buy any securities. Any public offering of securities in the United States must be made by means of a prospectus containing detailed information about the company and management, as well as financial statements. ‘United States’ and ‘U.S. person’ have the respective meanings assigned in Regulation S under the U.S Securities Act.

      ABOUT NORTH SHORE

      The nuclear power industry is in growth mode as more nuclear power will be required to meet the world’s ambitious CO2 emission-reduction goals and the needs of new power-intensive technologies like AI. In this environment, new discoveries of economic uranium deposits will be very valuable, especially in established uranium-producing jurisdictions like Saskatchewan and New Mexico. North Shore is well-positioned to become a major force in exploration for economic uranium deposits. The Company is working to achieve this goal by exploring its Falcon and West Bear properties at the eastern margin of the Athabasca Basin in Saskatchewan, expanding its exploration efforts to include the Grants Uranium District in New Mexico and by evaluating other quality opportunities in the United States and Canada to complement its portfolio of uranium properties. North Shore summarized its exploration efforts at its Falcon property in the Company’s May 27, 2025 news release. For more information about the Rio Puerco property, see the Company’s June 24, 2025 news release.

      ON BEHALF OF THE BOARD

      Brooke Clements,
      President, Chief Executive Officer and Director

      For further information:
      Please contact: Brooke Clements, President, Chief Executive Officer and Director
      Telephone: 604.536.2711
      Email: b.clements@northshoreuranium.com
      www.northshoreuranium.com

      Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

      Forward-Looking Statements

      This news release contains forward-looking statements that are based on the Company’s current expectations and estimates. Forward-looking statements are frequently characterized by words such as ‘plan’, ‘project’, ‘appear’, ‘interpret’, ‘coincident’, ‘potential’, ‘confirm’, ‘suggest’, ‘evaluate’, ‘encourage’, ‘likely’, ‘anomaly’, ‘continuous’ and variations of these words as well as other similar words or statements that certain events or conditions ‘could’, ‘may’, ‘should’, ‘would’ or ‘will’ occur. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual events or results to differ materially from estimated or anticipated events or results implied or expressed in such forward-looking statements. Such factors include, among others: the highly speculative nature of the Property given the early-stage nature of Rio Puerco; the ability of the Company to meet the Milestones; the ability of the Company to acquire up to 87.5% of the Project; the creation of a joint venture between the Company and Resurrection; the Bonus Payment to Resurrection; the actual results of current and planned exploration activities including the potential for the definition of a mineral deposit of potential economic value at the Company’s Falcon property in Saskatchewan and Rio Puerco in New Mexico; that drilling results, geophysical survey results and/or interpretations thereof define potentially mineralized corridors; results from future exploration programs including drilling; interpretation and meaning of completed and future geophysical surveys; conclusions of future economic evaluations; changes in project parameters as plans to continue to be refined; possible variations in grades of mineralization and/or future actual recovery rates; accidents, labour disputes and other risks of the mining industry; the availability of sufficient funding on terms acceptable to the Company to complete the planned work programs; delays in obtaining governmental approvals or financing; and fluctuations in metal prices. There may be other factors that cause actions, events or results not to be as anticipated, estimated, or intended. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events, or results or otherwise. Forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to the inherent uncertainty therein. Any forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement.

      Source

      Click here to connect with North Shore Uranium (TSXV:NSU) to receive an Investor Presentation

      This post appeared first on investingnews.com

      THE SANTA ROSA PLATEAU ECOLOGICAL RESERVE, Calif. — The scientist traipses to a pond wearing rubber boots but he doesn’t enter the water. Instead, Brad Hollingsworth squats next to its swampy edge and retrieves a recording device the size of a deck of cards. He then opens it up and removes a tiny memory card containing 18 hours of sound.

      Back at his office at the San Diego Natural History Museum, the herpetologist — an expert in reptiles and amphibians — uses artificial intelligence to analyze the data on the card. Within three minutes, he knows a host of animals visit the pond — where native red-legged frogs were reintroduced after largely disappearing in Southern California. There were owl hoots, woodpecker pecks, coyote howls and tree frog ribbits. But no croaking from the invasive bullfrog, which has decimated the native red-legged frog population over the past century.

      It was another good day in his efforts to increase the population of the red-legged frog and restore an ecosystem spanning the U.S.-Mexico border. The efforts come as the Trump administration builds more walls along the border, raising concerns about the impact on wildlife.

      At 2 to 5 inches long, red-legged frogs are the largest native frogs in the West and once were found in abundance up and down the California coast and into Baja California in Mexico.

      The species is widely believed to be the star of Mark Twain’s 1865 short story, “The Celebrated Jumping Frog of Calaveras County,” and their crimson hind legs were eaten during the Gold Rush. But as the red-legged frog declined in numbers, the bullfrog — with its even bigger hind legs — was introduced to menus during California’s booming growth in the late 19th and early 20th centuries.

      AP correspondent Ed Donahue reports on an international effort to bring back a type of frog.

      The red-legged frog population was decimated by the insatiable appetite of the bullfrogs and the disease the non-native species brought in, but also because it lost much of its habitat to drought and human development in the shape of homes, dams and more.

      Hollingsworth couldn’t estimate the number of red-legged frogs that remain but said they have disappeared from 95% of their historical range in Southern California.

      A man taking a photo on an iPhone of a a red-legged froglet sitting on his hand
      Brad Hollingsworth records an image of a red-legged froglet in a restoration pond on Aug. 11, on a ranch outside of El Coyote, Mexico.Gregory Bull / AP

      Robert Fisher of the U.S. Geological Survey’s Amphibian Research and Monitoring Initiative Program searched for the frog for decades across 250 miles from Los Angeles to the border. He found just one in 2001 and none after that.

      Scientists using DNA from red-legged frogs captured in Southern California before their disappearance discovered they were more genetically similar to the population in Mexico than any still in California.

      In 2006, Fisher, Hollingsworth and others visited Baja where they had heard of a small population of red-legged frogs. Anny Peralta, then a student of Hollingsworth at San Diego State University, joined them. They found about 20 frogs, and Peralta was inspired to dedicate her life to their recovery.

      Peralta and her husband established the nonprofit Fauna del Noroeste in Ensenada, Mexico, which aims to promote the proper management of natural resources. In 2018, they started building ponds in Mexico to boost the frog population that would later provide eggs to repopulate the species across the border.

      But just as they were preparing to relocate the egg masses, the COVID-19 pandemic hit. Peralta and the U.S. scientists scrambled to secure permits for the unusual cargo and a pilot to fly the two coolers of eggs closer to the border. The rest of their journey north was by road, after the eggs passed a U.S. border guard inspection.

      Over the past five years, Hollingsworth and his team have searched for sounds to prove their efforts to repopulate ponds in Southern California worked.

      On Jan. 30, he heard the quiet, distinct grunting of the red-legged frog’s breeding call in an audio flagged by AI.

      “It felt like a big burden off my shoulder because we were thinking the project might be failing,” Hollingsworth said. “And then the next couple nights we started hearing more and more and more, and more, and more.”

      Over the next two months, two males were heard belting it out on microphone 11 at one of the ponds. In March, right below the microphone, the first egg masse was found, showing they had not only hatched from the eggs brought from Mexico but had gone on to produce their own eggs in the United States.

      Conservationists are increasingly turning to artificial intelligence to monitor animals on the brink of extinction, track the breeding of reintroduced species and collect data on the impact of climate change and other threats.

      Herpetologists are building on the AI-powered tools already used to analyze datasets of bird sounds, hoping that it might help build audio landscapes to identify amphibians and track their behavior and breeding patterns, said Zachary Principe of The Nature Conservancy, which is working with the museum on the red-legged frog project. The tools could also help scientists analyze tens of thousands of audio files collected at universities, museums and other institutions.

      Scientists working to restore the red-legged frog population in Southern California hope to soon be provided with satellite technology that will send audio recordings to their phones in real time, so they can act immediately if any predators — in particular bullfrogs — are detected.

      A red-legged froglet leaping from a human hand
      Herpetologist Bennet Hardy holds a leaping red-legged froglet in a restoration pond on a ranch outside of El Coyote, Mexico.Gregory Bull / AP

      It could also help track the movement of the frogs, which can be difficult to find in the wild, especially because cold-blooded creatures cannot be detected using thermal imagery.

      The AI analysis of the pond audio has saved time for Hollingsworth and the others, who previously had to painstakingly listen to countless hours of audio files to detect the calls of the red-legged frog — which resembles the sound of a thumb being rubbed on a balloon — over the cacophony of other animals.

      “There’s tree frogs calling, there’s cows mooing, a road nearby with a motorcycle zooming back and forth,” Hollingsworth said of the ponds’ audio landscape. “There’s owls, there’s ducks splashing, just all this noise”

      The red-legged frog is the latest species to see success from binational cooperation along the near-2,000-mile border spanning California, Arizona, New Mexico and Texas. Over the years, Mexican gray wolves have returned to their historic range in the southwestern U.S. and in Mexico, while the California Condor now soars over skies from Baja to Northern California.

      Based off the latest count, scientists estimate more than 100 adult red-legged frogs are in the Southern California ponds, and tadpoles were spotted at a new site.

      The team plans to continue transporting egg masses from Baja, where the population has jumped from 20 to as many as 400 adult frogs, with the hope of building thriving populations on both sides of the border. Already the sites are seeing fewer mosquitos that can carry diseases like dengue and Zika.

      A restoration pond in Baja that Peralta’s organization built recently teemed with froglets, their tiny eyes bobbing on its aquatic fern-covered surface. They could, one day, lay eggs for relocation to the U.S.

      “They don’t know about borders or visas or passports,” Peralta said of the frogs. “This is just their habitat, and these populations need to reconnect. I think this shows that we can restore this ecosystem.”

      This post appeared first on NBC NEWS

      The nominee President Donald Trump tapped to serve as ambassador to a United Nations office charged with overseeing global aviation standards has a checkered tax history and background donating to Democrats and political opponents of the president, a Fox News Digital review of the nominee’s public records found. 

      The White House and Trump allies, however, have doubled down in support of the nominee, saying he will assist the administration in ‘ushering in the Golden Age of aviation.’ 

      Jeffrey Anderson was tapped to lead the International Civil Aviation Organization in July, when the White House published a list of nominations to fill various roles, from the International Civil Aviation Organization ambassadorship to director of the Mint to membership with the National Labor Relations Board. Anderson is a U.S. Navy veteran who worked as a commercial airline captain for more than 34 years, retiring from that role earlier in 2025, according to his LinkedIn. 

      The International Civil Aviation Organization is a U.N. office based in Montreal that is charged with overseeing international aviation standards, including issues related to safety, navigation and environmental protection. The role had sat vacant for the past three years, when the former ambassador, pilot Chesley ‘Sully’ Sullenberger, stepped down in 2022. 

      Sullenberger gained widespread applause in 2009, when the US Airways pilot landed Flight 1549 on the Hudson River after a bird strike disabled both engines — an event known as the ‘Miracle on the Hudson.’

      Anderson is a former Delta Air Lines pilot whose nomination drew ire from the Air Line Pilots Association, a union that represents nearly 80,000 pilots across the U.S. and Canada, arguing his ‘only’ qualification was supporting an effort to raise the mandatory pilot retirement age. 

      The union opposes increasing the mandatory retirement from 65 years of age to 67, arguing it ‘would leave the United States as an outlier in the global aviation space and create chaos on pilot labor, and international and domestic flight operations,’ the group’s statement in July read.

      Fox News Digital took a look back at Anderson’s political campaign contributions and found he donated to a handful of Democratic candidates often hostile to Trump and his policies. 

      He also made a handful of small dollar donations to Republican Nikki Haley during the 2024 campaign cycle, when the former U.S. ambassador to the U.N. ran against Trump, whom she slammed as ‘unhinged’ while on the campaign trail before dropping out of the race and endorsing Trump as the GOP nominee for president. 

      Anderson contributed at least $200 to Haley during the month of February 2024, when Haley and Trump were the only GOP candidates left in the primary race, according to four small dollar donations recorded by the Federal Election Commission. 

      The former pilot also donated to Shawn Harris, the former Democratic opponent who tried to unseat Republican Georgia Rep. Marjorie Taylor Greene in the 2024 cycle. The $100 donation was made in September 2024 through ActBlue, the Democratic Party’s massive fundraising arm, and earmarked for the Democratic candidate who ultimately failed to oust Greene. 

      Harris’ campaign included slamming Trump and characterizing him as a politician who acts as a ‘king’ and threatens democracy. 

      Anderson’s political donations to Democrats stretch back years, including in 2017 when he donated to Democrats, such as former House candidate Dan Ward in Virginia and former Rep. Peter DeFazio of Oregon — both of whom received $250 contributions from Anderson that year, according to election records. 

      Both Democrats had slammed Trump and his policies across his first administration, including DeFazio declaring after the Jan. 6, 2021, breach of the Capitol that: ‘Donald Trump is a threat to our democracy, national security and the safety of all Americans. He must be removed from office immediately.’ 

      The former Delta pilot has also landed in hot water over unpaid taxes, Fox News Digital found. IRS records show Anderson and his wife had over $426,000 in unpaid federal taxes across seven years from 2013 to 2019, raising concerns that his financial responsibility. The taxes were related to a ‘small business,’ according to the forms. 

      ‘Jeffrey Anderson isn’t a Trump Republican at all; he’s a liberal sleeper who slipped through the cracks of PPO (Presidential Personnel Office),’ a former Trump official told Fox Digital of Anderson’s political donations and tax history. 

      When approached for comment on the previous donations and tax issues, Anderson told Fox News Digital that at ‘the very least, some of your information is factually incorrect or tendered well out of context.’ Anderson did not respond when asked for additional details on what was ‘factually incorrect.’

      ‘At the very least, some of your information is factually incorrect or tendered well out of context. I am fully supportive of President Trump and his America First agenda. I have been fully vetted by the White House and appreciate the approval of the President, House Aviation Chair Troy Nehls and House T&I Chair Sam Graves, among others. I look forward to advancing American interests as the next Permanent Representative to ICAO,’ he wrote in a direct message on LinkedIn to Fox Digital in August, while adding that Trump is seeking to ‘move effectively forward in a space negligently left vacant by Biden.’

      When asked about Anderson’s tax history and donations to Democrats and Trump opponents, a White House official told Fox Digital: ‘Jeffrey Alderson is highly qualified to serve as America’s ambassador to the ICAO, and he is a great choice to represent the President’s America First foreign policy agenda in the international aviation community.’

      Fox News Digital additionally reached out to the State Department, which helps manage the vetting of potential ambassador nominees, for comment and was directed the White House’s statement. 

      The former pilot himself also floated a run for political office more than a decade ago in Georgia as a Democrat, according to a local Georgia news report that called him ‘prospective Democratic Congressional candidate Jeff Anderson.’ In an opinion piece published that same year, titled ‘The sinking Democratic Party in Georgia is bad news for everyone,’ Anderson was described as a ‘a 2010 Independent candidate for the U.S. House in Georgia’s 11th District.’ 

      While old social media posts on X show Anderson celebrated former President Biden’s 2012 DNC speech at the time as ‘wonderful American message: major concepts, not petty; Democratic, but not commercially political.’ While other tweets targeted the NRA and celebrated how Anderson ‘politely but firmly faced’ NRA representatives and gun manufacturers on ‘sensible policy ideals’ back in 2023, according to a review of the X account @JeffAndersonPAI that ceased activity back in 2014.  

      In addition to the White House defending Anderson’s nomination, Texas Republican Rep. Troy Nehls, who serves as chairman of the House Transportation and Infrastructure Subcommittee on Aviation, told Fox Digital that Anderson will help usher in ‘the Golden Age of aviation’ under the Trump administration. 

      ‘As Chairman of the House Aviation Subcommittee, I have complete confidence in Jeffrey Anderson to serve as ambassador to the International Civil Aviation Organization (ICAO),’ Nehls said in comment to Fox Digital in August. ‘Mr. Anderson served as a naval aviator and has more than three decades of experience as a pilot for Delta. He is, without a doubt, qualified to represent the United States of America at ICAO, where his first-hand experience with the aviation industry will play a crucial role in advancing President Trump’s mission of ushering in the Golden Age of aviation.’

      A board member of a pilots group called Experienced Pilots Advancing Aviation Safety, added that he fully backs Anderson’s nomination, citing his honesty and credentials as an airline captain. The Experienced Pilots Advancing Aviation Safety, which endorsed Anderson’s nomination, also advocates raising the mandatory retirement age for airline pilots, arguing experienced pilots lead to safer skies and can mentor the next generation instead of ‘forced retirements of America’s most experienced aviators,’ according to its website. 

      ‘I feel 100% confident in Captain Anderson’s honesty and professional credentials. Having flown aircraft around the world in international operations for the past 40 years in the Marine Corps and Delta Airlines, and my working with and in association with ICAO and IATA, I feel Jeff would be a perfect fit for this position as it seems the president of the United States does also,’ the board member told Fox Digital in emailed comment earlier in August. 

      International aviation rules currently prohibit airline pilots older than 65 from flying. Global airline groups such as the International Air Transport Association has called on the ICAO to consider raising the international pilot retirement age to 67. The UN General Assembly will convene on Sept. 23, with the ICAO expected to consider the proposal, Reuters reported on Thursday. 

      Anderson’s nomination was sent to the Senate in July, and was then referred to the Committee on Foreign Relations. The nomination is currently awaiting final confirmation proceedings. 

      This post appeared first on FOX NEWS

      A Centers for Disease Control and Prevention official who posted his resignation letter on social media used the term ‘pregnant people’ and capped off his missive by including ‘he/his/him’ pronouns after his name.

      ‘I am writing to formally resign from my position as Director of the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention (CDC), effective August 28, 2025, close of business,’ Dr. Demetre Daskalakis wrote in the lengthy post on X.

      Daskalakis accused President Donald Trump’s administration of attempting ‘to erase transgender populations.’

      ‘For decades, I have been a trusted voice for the LGBTQ community when it comes to critical health topics. I must also cite the recklessness of the administration in their efforts to erase transgender populations, cease critical domestic and international HIV programming, and terminate key research to support equity as part of my decision,’ he wrote.

      The inclusion of pronouns and the term ‘pregnant people’ caught people’s attention.

      ‘This resignation is a huge win for the Trump administration and the American people. We don’t need anyone who can’t understand basic biology working at the CDC,’ noted Jeremy Redfern, communications director for Florida Attorney General James Uthmeier.

      RFK Jr speaks out against AAP

      Karol Markowicz tweeted, ‘No one who uses ‘pregnant people’ should work at the CDC. This isn’t hard.’ 

      Responding to Markowicz’s post, Florida Gov. Ron DeSantis wrote, ‘Example of how ‘trusting the science’ really means following the political science and perpetuating the prevailing narrative…’ He added, ‘Embracing evidence-based medicine should be the bare minimum for working at the CDC…’

      Daskalakis suggested that the Department of Health and Human Services is on a ‘dangerous’ path.

      ‘I am unable to serve in an environment that treats CDC as a tool to generate policies and materials that do not reflect scientific reality and are designed to hurt rather than to improve the public’s health,’ he wrote.

      ‘I wish the CDC continued success in its vital mission and that HHS reverse its dangerous course to dismantle public health as a practice and as an institution. If they continue the current path, they risk our personal well-being and the security of the United States,’ Daskalakis concluded at the end of his message.

      Fox News Digital reached out to HHS for comment on Thursday.

      This post appeared first on FOX NEWS

      Foxit, a major PDF software company founded in China, removed any mention of its various U.S. government customers from its website after Fox News Digital began asking questions about its government ties and Chinese connections.

      The company develops PDF software for reading, editing and signing documents, with customers ranging from businesses to U.S. agencies. Foxit was founded in 2001 in Fuzhou, China, by Eugene Xiong. Its parent company — Fujian Foxit Software Development Joint Stock Co., Ltd. — is traded on the Shanghai stock market and oversees a U.S. subsidiary based in Fremont, Calif.

      Until Fox News Digital began pressing Foxit on its background, the company’s website touted clients across the federal government — from the Missile Defense Agency (MDA) and State Department to the Army, Navy, Air Force, Department of Homeland Security (DHS), Food and Drug Administration (FDA), U.S. courts and the Department of Transportation.

      But following Fox News Digital’s request for comment, Foxit scrubbed any mention of U.S. government customers from its site. The company did not respond to questions.

      Over the course of reporting, multiple agencies confirmed they had either removed Foxit products or no longer maintained active contracts with Foxit’s U.S. subsidiary. 

      An MDA spokesperson said Foxit had been used on an isolated network ‘not connected to any operational missile defense system’ but is ‘no longer in any MDA system.’ The spokesperson did not say when Foxit had been removed from its systems but added that the team behind the initial decision to use the software is no longer with the agency, and that an updated review of all software is underway. 

      A State Department source said small Foxit contracts had existed in the past but were terminated, though did not clarify when.

      Before the website purge, Foxit even published ‘case studies’ on work with U.S. Citizenship and Immigration Services and the FDA. A DHS source, however, told Fox News Digital that Foxit is now ‘specifically identified and listed on our prohibited software list.’

      The FDA handles trade secrets, sensitive clinical trial data and even biodefense-related health information. The agency did not return a request for comment on whether it is still using Foxit. 

      The Department of Justice likewise confirmed Foxit was removed from its networks last year after a security review.

      Other agencies, including the Office of the Secretary of Defense (OSD) and the National Institutes of Health, acknowledged receiving questions from Fox News Digital but did not confirm current usage.

      Foxit is difficult to track in publicly available records: government purchases may be logged under distributors, integrators or resellers rather than the company itself.

      Fox News Digital identified dozens of solicitation requests — documents federal agencies issue when seeking bids for goods and services — that specifically mentioned Foxit software, from the Army, Navy, NIH, NASA, the Defense Department and the General Services Administration. Which of those turned into finalized contracts is unclear.

      One known Foxit contract with OSD expired in 2023.

      On its U.S. website, Foxit emphasizes its California headquarters and ‘global’ reach, without mention of its Chinese listing. On its Chinese-language site, however, Foxit highlights clients such as the Chinese Ministry of Foreign Affairs, the State Intellectual Property Office, and the National Standards Committee. In 2023, it announced a partnership with China Media Group, which operates under the Chinese Communist Party’s Publicity Department.

      Its Chinese website lists offices in Fuzhou, Beijing, Nanjing and Hefei. 

      U.S. agencies typically contract through the California-based Foxit Software Inc., not the Chinese parent, allowing Foxit to present itself as a U.S.-based company. Still, Foxit’s parent company remains subject to Chinese law — including the 2017 National Intelligence Law, which compels companies to assist Chinese intelligence if requested. 

      One analyst questioned whether the corporate separateness could fully insulate the U.S. subsidiary from the interests of the Chinese parent. 

      ‘It sounds especially similar to the TikTok argument. We’re doing everything here, all the data is located here, we have TikTok USA. We’re a Singaporean company, we have no relations with the Chinese mainland – outside of our corporate structure, which is almost wholly owned by a Chinese based company,’ said Joel Thayer, a Washington-based tech and telecommunications attorney.

      ‘Chinese companies are masters of concealing their intentions through corporate filings and corporate infrastructure,’ he said.

      Foxit counts Idax.ai as its subsidiary, a company specifically tailored to redact sensitive documents. ‘The company’s AI-powered solutions are aimed at professionals across various industries, including healthcare, finance, real estate, law, and government,’ according to a branded content release in NY Weekly.

      Fox News Digital could not determine whether Idax has been used by government agencies.

      Foxit claims to have 750 million users and over 425,000 clients around the world, with business centers not just in the U.S. and China but Japan, Europe and Australia, with plans to expand into Russia, Brazil and India. 

       Critics warn that even seemingly routine data could be of intelligence value.

      ‘Even if Foxit isn’t being used for secret documents, the information the company could potentially glean would be invaluable to the CCP,’ said Thayer. 

      ‘You are basically banking on it that the platform isn’t behind the veil, collecting an immense amount of data about what contracts and services are being provided to our government,’ he said.

      Foxit originally positioned itself as a cheaper alternative to Adobe Acrobat. But China tech watchers warn the discount may come with hidden risks.

      ‘That’s invaluable information for any of our adversaries – how much money a contract is worth, what services are being rendered, what technologies are they looking at, what are they hiring people to do, what the government is looking into… competitors would kill for that information,’ Thayer said. 

      This post appeared first on FOX NEWS